INmune Bio Inc. is a publicly traded (NASDAQ: INMB), clinical-stage biotechnology company focused on developing treatments that target the innate immune dysfunction to fight disease. The Company’s ...
Stromal endometriosis is a term used to specify the nature of tissue present in endometriosis. A diagnosis featuring this type of cell could mean endometrial lesions are more challenging to spot ...
A new study uncovers a crucial molecular pathway that enables endometrial cells to survive oxidative stress, fueling endometriosis progression. Researchers found the CHK1/SGK1 axis plays a pivotal ...
Within the tumor microenvironment, networks of cells and molecular signals form a dynamic landscape that drives disease progression.
The US Food and Drug Administration (FDA) has approved remestemcel-L (Ryoncil, Mesoblast Ltd), an allogeneic bone marrow‒derived mesenchymal stromal cell (MSC) therapy for steroid-refractory acute ...
Mucosal surfaces serve as critical battlegrounds where the immune system must balance tolerance to commensal organisms with rapid defense against pathogens.
Dec 18 (Reuters) - The U.S. Food and Drug Administration on Wednesday approved Mesoblast's (MSB.AX), opens new tab cell therapy for treating a type of complication that occurs after a stem cell or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback